Russia’s COVID-19 vaccine, Sputnik-V arrives in India, clinical trials to begin soon: Reports


New Delhi: As the world battles the COVID-19 pandemic, trials for different vaccine candidates are being conducted all around the world, to test their efficacy and safety against the novel coronavirus or SARS-CoV-2, the virus that causes COVID-19 disease. Good news is now coming in for vaccine development and testing in India, as it has been reported that Russia’s COVID-19 vaccine, Sputnik-V, has arrived in the country, and trials for the same are likely to begin soon.

Sputnik V, the vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology had recently been reported to show 92 per cent efficacy against the virus based on the first interim data from the largest double-blind, randomized, placebo-controlled phase 3 clinical trials in Russia involving 40,000 volunteers.

Dr Reddy’s laboratory, Hyderabad, had got approvals from the DCGI to conduct phase 2/3 trials of the vaccine in India.

A video that has surfaced online shows containers with logos of Sputnik V and Dr Reddy’s being unloaded from a small truck. Accoridng to a report by The New Indian Express, a senior official from the pharma company has confirmed that the video is authentic, and the Sputnik-V vaccine has indeed arrived in India.

Apart from Sputnik-V, Pfizer-BioNTech’s vaccine candidate has also shown 90 per cent efficacy in late-stage trials, raising hopes for the availability of an effective and safe vaccine against the novel coronavirus.

On August 11, Russia became the first country in the world to register its vaccine, Sputnik-V for public use, even as various experts raised questions on its safety and efficacy.

[Read More…]